• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Latest News about NASDAQ:IMUX

    Recent news which mentions NASDAQ:IMUX

    Immunic Inc. CEO Daniel Vitt Highlights Advances in MS Treatment on World MS Day
    Tags NASDAQ:IMUX
    From News Direct
    Immunic CMO discusses role of clinical trials in biotech development for Clinical Trials Day
    Tickers IMUX
    Tags NASDAQ:IMUX
    From News Direct
    Immunic chief medical officer discusses promising treatments to mark World IBD Day
    Tickers IMUX
    Tags NASDAQ:IMUX
    From News Direct
    Immunic highlights IMU-856 gastrointestinal candidate to mark International Celiac Day
    Tickers IMUX
    Tags NASDAQ:IMUX
    From News Direct
    Immunic CEO Dr Daniel Vitt discusses key Q1 advances and upcoming milestones
    Tickers IMUX
    Tags NASDAQ:IMUX
    From News Direct
    IMUX Stock Earnings: Immunic Misses EPS for Q1 2024
    Tickers IMUX
    Tags Market News Earnings Reports IMUX
    From InvestorPlace
    Immunic Phase 2 EMPhASIS trial data highlighted in peer-reviewed neurology journal
    Tickers IMUX
    Tags NASDAQ:IMUX
    From News Direct
    Immunic CEO Dr Daniel Vitt marks International Day of Immunology with discussion on its crucial role
    Tags NASDAQ:IMUX
    From News Direct
    Immunic CMO discusses complexities of multiple sclerosis to mark MS Awareness Month
    Tickers IMUX
    Tags NASDAQ:IMUX
    From News Direct
    Immunic secures key patent, boosting MS drug exclusivity and global IP strategy
    Tags NASDAQ:IMUX
    From News Direct
    Immunic to reveal promising MS treatment data in two poster presentations at ACTRIMS Forum 2024
    Tags NASDAQ:IMUX
    From News Direct
    Immunic reports successful 2023 and prepares for key 2025 milestones
    Tags NASDAQ:IMUX
    From News Direct
    Immunic focusing on business development during Q4
    Tags NASDAQ:IMUX
    From News Direct
    Immunic CSO hails "great" progress with MS program
    Tickers IMUX
    Tags NASDAQ:IMUX
    From News Direct
    Immunic "super excited" about latest PMS trial data
    Tickers IMUX
    Tags NASDAQ:IMUX
    From News Direct
    Immunic CEO hails "great day" after completing IMU-838 phase 2 trial enrolment
    Tickers IMUX
    Tags NASDAQ:IMUX
    From News Direct
    Immunic CEO says Q2 results "couldn't be better"
    Tickers IMUX
    Tags NASDAQ:IMUX
    From News Direct
    Immunic Inc eyeing "big step" for multiple sclerosis patients
    Tickers IMUX
    Tags NASDAQ:IMUX
    From News Direct
    Immunic Therapeutics shares IMU-856 mode of action and target for gastrointestinal diseases
    Tags NASDAQ:IMUX
    From News Direct
    Immunic ultimately hoping to "offer patients a new kind of treatment" for multiple sclerosis
    Tags NASDAQ:IMUX
    From News Direct
    Immunic says preclinical data for vidofludimus calcium is a milestone for its lead MS program
    Tags NASDAQ:IMUX
    From News Direct
    Immunic Inc set to bring relief with encouraging results
    Tickers IMUX
    Tags NASDAQ:IMUX
    From News Direct
    Immunic IMU-856 trial data "clearly goes beyond" initial expectations
    Tickers IMUX
    Tags NASDAQ:IMUX
    From News Direct
    Immunic gets a "positive surprise" from lead asset trial
    Tickers IMUX
    Tags NASDAQ:IMUX
    From News Direct
    2 Biotech Stocks to Take off Your Watchlist in 2022
    Tags :DNA NASDAQ:IMUX
    From StockNews.com
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.